Share This Article:

Characteristics of Mesenchymal Stem Cells under Hypoxia

Abstract Full-Text HTML XML Download Download as PDF (Size:133KB) PP. 11-19
DOI: 10.4236/cellbio.2013.21002    4,896 Downloads   8,590 Views   Citations


Mesenchymal stem cells (MSC) are considered non-hematopoietic multipotent stem cells with self-renewal properties and the ability to differentiate into a variety of mesenchymal tissues. Optimal conditions for the culture of these cells have been the subject of investigation for several years. In particular, ideal oxygen tension levels have not been established in the literature. In physiological environments, oxygen tension may vary from 12% in peripheral blood to 1% in the deep zone of cartilage regions. In any case, oxygen tension is considerably lower in vivo when compared with the normal atmosphere of standard cell culture conditions (21%). The objective of this study was to review the literature available on MSC characteristics (cell cycle, survival, proliferation, differentiation, morphology, immunophenotype, cytogenetics) when cultured under hypoxic conditions. Our focus on optimal culture conditions is justified by the key role currently played by these cells in regenerative medicine.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

B. Amorin, A. Alegretti, V. Valim, A. Silva, M. Silva, F. Sehn and L. Silla, "Characteristics of Mesenchymal Stem Cells under Hypoxia," CellBio, Vol. 2 No. 1, 2013, pp. 11-19. doi: 10.4236/cellbio.2013.21002.


[1] M. Dominici, K. Le Blanc, I. Mueller, I. Slaper-Corten-bach, F. Marini, D. Krause, R. Deans, A. Keating, D. Prockop and E. Horwitz, “Minimal Criteria for Defining Multipotent Mesenchymal Stromal Cells. The International Society for Cellular Therapy Position Statement,” Cytotherapy, Vol. 8, No. 4, 2006, pp. 315-317. doi:10.1080/14653240600855905
[2] S. P. Bruder, K. H. Kraus, V. M. Goldberg and S. Kadi-yala, “The Effect of Implants Loaded with Autologous Mesenchymal Stem Cells on the Healing of Canine Segmental Bone Defects,” The Journal of Bone Joint Surgery, Vol. 80, No. 7, 1998, pp. 985-996.
[3] A. J. Friedenstein, R. K. Chailakhjan and K. S. Lalykina, “The Development of Fibroblast Colonies in Monolayer Cultures of Guinea-Pig Bone Marrow and Spleen Cells,” Cell and Tissue Kinetics, Vol. 3, No. 4, 1970, pp. 393-403.
[4] D. J. Prockop, “Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues,” Science, Vol. 276, No. 5309, 1997, pp. 71-74. doi:10.1126/science.276.5309.71
[5] A. I. Caplan, “All MSCs Are Pericytes?” Cell Stem Cell, Vol. 3, No. 3, 2008, pp. 229-230. doi:10.1016/j.stem.2008.08.008
[6] M. F. Pittenger, A. M. Mackay, S. C. Beck, R. K. Jaiswal, R. Douglas, J. D. Mosca, M. A. Moorman, D. W. Simonetti, S. Craig and D. R. Marshak, “Multilineage Potential of Adult Human Mesenchymal Stem Cells,” Science, Vol. 284, No. 5411, 1999, pp. 143-147. doi:10.1126/science.284.5411.143
[7] P. D. Cooper, A. M. Burt and J. N. Wilson, “Critical Effect of Oxygen Tension on Rate of Growth of Animal Cells in Continuous Suspended Culture,” Nature, Vol. 182, No. 4648, 1958, pp. 1508-1509. doi:10.1038/1821508b0
[8] H. T. Zwartouw and J. C. Westwood, “Factors Affecting Growth and Glycolysis in Tissue Culture,” British Journal of Experimental Pathology, Vol. 39, No. 5, 1958, pp. 529-539.
[9] S. Aggarwal and M. F. Pittenger, “Human Mesenchymal Stem Cells Modulate Allogeneic Immune Cell Responses,” Blood, Vol. 105, No. 4, 2005, pp. 1815-1822. doi:10.1182/blood-2004-04-1559
[10] C. T. van Velthoven, A. Kavelaars, F. van Bel and C. J. Heijnen, “Mesenchymal Stem Cell Treatment after Neonatal Hypoxic-Ischemic Brain Injury Improves Behavioral Outcome and Induces Neuronal and Oligodendrocyte Regeneration,” Brain Behavior Immunity, Vol. 24, No. 3, 2010, pp. 387-393. doi:10.1016/j.bbi.2009.10.017
[11] L. F. Raheja, D. C. Genetos and C. E. Yellowley, “The Effect of Oxygen Tension on the Long-Term Osteogenic Differentiation and MMP/TIMP Expression of Human Mesenchymal Stem Cells,” Cells Tissues Organs, Vol. 191, No. 3, 2010, pp. 175-184. doi:10.1159/000235679
[12] L. F. Raheja, D. C. Genetos, A. Wong and C. E. Yellowley, “Hypoxic Regulation of Mesenchymal Stem Cell Migration: The Role of RhoA and HIF-1Alpha,” Cell Biology International, Vol. 35, No. 10, 2011, pp. 981-989. doi:10.1042/CBI20100733
[13] G. Y. Rochefort, B. Delorme, A. Lopez, O. Herault, P. Bonnet, P. Charbord, V. Eder and J. Domenech, “Multipotential Mesenchymal Stem Cells Are Mobilized into Peripheral Blood by Hypoxia,” Stem Cells, Vol. 24, No. 10, 2006, pp. 2202-2208. doi:10.1634/stemcells.2006-0164
[14] G. D’Ippolito, S. Diabira, G. A. Howard, B. A. Roos and P. C. Schiller, “Low Oxygen Tension Inhibits Osteogenic Differentiation and Enhances Stemness of Human MI-AMI Cells,” Bone, Vol. 39, No. 3, 2006, pp. 513-522. doi:10.1016/j.bone.2006.02.061
[15] L. Liu, Q. Yu, J. Lin, X. Lai, W. Cao, K. Du, Y. Wang, K. Wu, Y. Hu, L. Zhang, H. Xiao, Y. Duan and H. Huang, “Hypoxia-Inducible Factor-1alpha Is Essential for Hypoxia-Induced Mesenchymal Stem Cell Mobilization into the Peripheral Blood,” Stem Cells Development, Vol. 20, No. 11, 2011, pp. 1961-1971. doi:10.1089/scd.2010.0453
[16] R. Das, H. Jahr, G. J. van Osch and E. Farrell, “The Role of Hypoxia in Bone Marrow-Derived Mesenchymal Stem Cells: Considerations for Regenerative Medicine Approaches,” Tissue Engineering Part B Reviews, Vol. 16, No. 2, 2010, pp. 159-168. doi:10.1089/ten.teb.2009.0296
[17] C. Holzwarth, M. Vaegler, F. Gieseke, S. M. Pfister, R. Handgretinger, G. Kerst and I. Muller, “Low Physiologic Oxygen Tensions Reduce Proliferation and Differentiation of Human Multipotent Mesenchymal Stromal Cells,” BMC Cell Biology, Vol. 11, 2010, p. 11. doi:10.1186/1471-2121-11-11
[18] R. P. Hill, D. T. Marie-Egyptienne and D. W. Hedley, “Cancer Stem Cells, Hypoxia and Metastasis,” Seminars in Radiation Oncology, Vol. 19, No. 2, 2009, pp. 106- 111.
[19] A. Efimenko, E. Starostina, N. Kalinina and A. Stolzing, “Angiogenic Properties of Aged Adipose Derived Mesenchymal Stem Cells after Hypoxic Conditioning,” Journal of Translational Medicine, Vol. 9, 2011, p. 10. doi:10.1186/1479-5876-9-10
[20] S. P. Hung, J. H. Ho, Y. R. Shih, T. Lo and O. K. Lee, “Hypoxia Promotes Proliferation and Osteogenic Differentiation Potentials of Human Mesenchymal Stem Cells,” Journal of Orthopaedic Research, Vol. 30, No. 2, 2012, pp. 260-266. doi:10.1002/jor.21517
[21] I. Rosova, M. Dao, B. Capoccia, D. Link and J. A. Nolta, “Hypoxic Preconditioning Results in Increased Motility and Improved Therapeutic Potential of Human Mesenchymal Stem Cells,” Stem Cells, Vol. 26, No. 8, 2008, pp. 2173-2182. doi:10.1634/stemcells.2007-1104
[22] N. B. Nardi and S. Meirelles Lda, “Mesenchymal Stem-Cells: Isolation, in Vitro Expansion and Characterization,” Handbook of Experimental Pharmacology, Vol. 174, 2006, pp. 249-282. doi:10.1007/3-540-31265-X_11
[23] K. Le Blanc and D. Mougiakakos, “Multipotent Mesenchymal Stromal Cells and the Innate Immune System,” Nature Reviews Immunology, Vol. 12, No. 5, 2012, pp. 383-396. doi:10.1038/nri3209
[24] C. Lo Celso, J. W. Wu and C. P. Lin, “In Vivo Imaging of Hematopoietic Stem Cells and Their Microenvironment,” Journal of Biophotonics, Vol. 2, No. 11, 2009, pp. 619-631. doi:10.1002/ jbio.200910072
[25] Y. Shen and S. K. Nilsson, “Bone, Microenvironment and Hematopoiesis,” Current Opinion in Hematology, Vol. 19, No. 4, 2012, pp. 250-255.
[26] R. Schofield, “The Stem Cell System,” Biomedicine Pharmacotherapy, Vol. 37, No. 8, 1983, pp. 375-380.
[27] M. G. Cipolleschi, P. Dello Sbarba and M. Olivotto, “The Role of Hypoxia in the Maintenance of Hematopoietic Stem Cells,” Blood, Vol. 82, No. 7, 1993, pp. 2031-2037.
[28] D. P. Lennon, J. M. Edmison and A. I. Caplan, “Cultivation of Rat Marrow-Derived Mesenchymal Stem Cells in Reduced Oxygen Tension: Effects on in Vitro and in Vivo Osteochondrogenesis,” Journal of Cellular Physiology, Vol. 187, No. 3, 2001, pp. 345-355. doi:10.1002/jcp.1081
[29] T. Ma, W. L. Grayson, M. Frohlich and G. Vunjak-Novakovic, “Hypoxia and Stem Cell-Based Engineering of Mesenchymal Tissues,” Biotechnology Progress, Vol. 25, No. 1, 2009, pp. 32-42. doi:10.1002/btpr.128
[30] Z. Ivanovic, “Hypoxia or in Situ Normoxia: The Stem Cell Paradigm,” Journal of Cellular Physiology, Vol. 219, No. 2, 2009, pp. 271-275. doi:10.1002/jcp.21690
[31] I. G. Winkler, V. Barbier, R. Wadley, A. C. Zannettino, S. Williams and J. P. Levesque, “Positioning of Bone Marrow Hematopoietic and Stromal Cells Relative to Blood Flow in Vivo: Serially Reconstituting Hematopoietic Stem Cells Reside in Distinct Nonperfused Niches,” Blood, Vol. 116, No. 3, 2010, pp. 375-385.
[32] W. Zhu, J. Chen, X. Cong, S. Hu and X. Chen, “Hypoxia and Serum Deprivation-Induced Apoptosis in Mesenchymal Stem Cells,” Stem Cells, Vol. 24, No. 2, 2006, pp. 416-425. doi:10.1634/stemcells. 2005-0121
[33] S. Lord-Dufour, I. B. Copland, L. C. Levros Jr., M. Post, A. Das, C. Khosla, J. Galipeau, E. Rassart and B. Annabi, “Evidence for Transcriptional Regulation of the Glucose-6-Phosphate Transporter by HIF-1Alpha: Targeting G6PT with Mumbaistatin Analogs in Hypoxic Mesenchymal Stromal Cells,” Stem Cells, Vol. 27, No. 3, 2009, pp. 489-497. doi:10.1634/stemcells.2008-0855
[34] J. A. Wang, T. L. Chen, J. Jiang, H. Shi, C. Gui, R. H. Luo, X. J. Xie, M. X. Xiang and X. Zhang, “Hypoxic Preconditioning Attenuates Hypoxia/Reoxygenation-Induced Apoptosis in Mesenchymal Stem Cells,” Acta Pharmacologica Sinica, Vol. 29, No. 1, 2008, pp. 74-82. doi:10.1111/j.1745-7254.2008.00716.x
[35] W. L. Grayson, F. Zhao, B. Bunnell and T. Ma, “Hypoxia Enhances Proliferation and Tissue Formation of Human Mesenchymal Stem Cells,” Biochemical and Biophysical Research Communications, Vol. 358, No. 3, 2007, pp. 948-953.
[36] S. P. Hung, J. H. Ho, Y. R. Shih, T. Lo and O. K. Lee, “Hypoxia Promotes Proliferation and Osteogenic Differentiation Potentials of Human Mesenchymal Stem Cells,” Journal of Orthopaedic Research, Vol. 30, No. 2, 2012, pp. 260-266. doi:10.1002/jor.21517
[37] E. Martin-Rendon, S. J. Hale, D. Ryan, D. Baban, S. P. Forde, M. Roubelakis, D. Sweeney, M. Moukayed, A. L. Harris, K. Davies and S. M. Watt, “Transcriptional Profiling of Human Cord Blood CD133+ and Cultured Bone Marrow Mesenchymal Stem Cells in Response to Hypoxia,” Stem Cells, Vol. 25, No. 4, 2007, pp. 1003-1012. doi:10.1634/stemcells.2006-0398
[38] H. Ren, Y. Cao, Q. Zhao, J. Li, C. Zhou, L. Liao, M. Jia, H. Cai, Z. C. Han, R. Yang, G. Chen and R. C. Zhao, “Proliferation and Differentiation of Bone Marrow Stromal Cells under Hypoxic Conditions,” Biochemical and Biophysical Research Communications, Vol. 347, No. 1, 2006, pp. 12-21. doi:10.1016/j.bbrc.2006.05.169
[39] S. C. Hung, R. R. Pochampally, S. C. Hsu, C. Sanchez, S. C. Chen, J. Spees and D. J. Prockop, “Short-Term Exposure of Multipotent Stromal Cells to Low Oxygen Increases Their Expression of CX3CR1 and CXCR4 and Their Engraftment in Vivo,” PLoS One, Vol. 2, No. 5, 2007, p. e416. doi:10.1371/journal.pone.0000416
[40] D. Baksh, L. Song and R. S. Tuan, “Adult Mesenchymal Stem Cells: Characterization, Differentiation, and Application in Cell and Gene Therapy,” Journal of Cellular and Molecular Medicine, Vol. 8, No. 3, 2004, pp. 301- 316. doi:10.1111/j.1582-4934.2004.tb00320.x
[41] J. Huang, F. Deng, L. Wang, X. R. Xiang, W. W. Zhou, N. Hu and L. Xu, “Hypoxia Induces Osteogenesis-Related Activities and Expression of Core Binding Factor Alpha1 in Mesenchymal Stem Cells,” The Tohoku Journal of Experimental Medicine, Vol. 224, No. 1, 2011, pp. 7-12.
[42] T. Fink, L. Abildtrup, K. Fogd, B. M. Abdallah, M. Kassem, P. Ebbesen and V. Zachar, “Induction of Adipocyte-Like Phenotype in Human Mesenchymal Stem Cells by Hypoxia,” Stem Cells, Vol. 22, No. 7, 2004, pp. 1346-1355. doi:10.1634/stemcells.2004-0038
[43] C. Fehrer, R. Brunauer, G. Laschober, H. Unterluggauer, S. Reitinger, F. Kloss, C. Gully, R. Gassner and G. Lepperdinger, “Reduced Oxygen Tension Attenuates Differentiation Capacity of Human Mesenchymal Stem Cells and Prolongs Their Lifespan,” Aging Cell, Vol. 6, No. 6, 2007, pp. 745-757. doi:10.1111/j.1474-9726.2007.00336.x
[44] E. Potier, E. Ferreira, R. Andriamanalijaona, J. P. Pujol, K. Oudina, D. Logeart-Avramoglou and H. Petite, “Hypoxia Affects Mesenchymal Stromal Cell Osteogenic Differentiation and Angiogenic Factor Expression,” Bone, Vol. 40, No. 4, 2007, pp. 1078-1087. doi:10.1016/j.bone.2006.11.024
[45] C. Wan, J. Shao, S. R. Gilbert, R. C. Riddle, F. Long, R. S. Johnson, E. Schipani and T. L. Clemens, “Role of HIF-1Alpha in Skeletal Development,” Annals of New York Academy of Science, Vol. 1192, 2010, pp. 322-326. doi:10.1111/j.1749-6632.2009.05238.x
[46] M. G. Valorani, E. Montelatici, A. Germani, A. Biddle, D. D’Alessandro, R. Strollo, M. P. Patrizi, L. Lazzari, E. Nye, W. R. Otto, P. Pozzilli and M. R. Alison, “Pre-Culturing Human Adipose Tissue Mesenchymal Stem Cells under Hypoxia Increases Their Adipogenic and Osteogenic Differentiation Potentials,” Cell Proliferation, Vol. 45, No. 3, 2012, pp. 225-238. doi:10.1111/j.1365-2184.2012.00817.x
[47] I. Muller, M. Vaegler, C. Holzwarth, N. Tzaribatchev, S. M. Pfister, B. Schutt, P. Reize, J. Greil, R. Handgretinger and M. Rudert, “Secretion of Angiogenic Proteins by Human Multipotent Mesenchymal Stromal Cells and Their Clinical Potential in the Treatment of Avascular Osteonecrosis,” Leukemia, Vol. 22, No. 11, 2008, pp. 2054-2061. doi:10.1038/leu.2008.217
[48] A. Salim, R. P. Nacamuli, E. F. Morgan, A. J. Giaccia and M. T. Longaker, “Transient Changes in Oxygen Tension Inhibit Osteogenic Differentiation and Runx2 Expression in Osteoblasts,” Journal of Biological Chemistry, Vol. 279, No. 38, 2004, pp. 40007-40016. doi:10.1074/jbc.M403715200
[49] K. Scherer, M. Schunke, R. Sellckau, J. Hassenpflug and B. Kurz, “The Influence of Oxygen and Hydrostatic Pressure on Articular Chondrocytes and Adherent Bone Marrow Cells in Vitro,” Biorheology, Vol. 41, No. 3-4, 2004, pp. 323-333.
[50] M. Kanichai, D. Ferguson, P. J. Prendergast and V. A. Campbell, “Hypoxia Promotes Chondrogenesis in Rat Mesenchymal Stem Cells: A Role for AKT and Hypoxia-Inducible Factor (HIF)-1Alpha,” Journal of Cellular Physiology, Vol. 216, No. 3, 2008, pp. 708-715. doi:10.1002/jcp.21446
[51] J. C. Robins, N. Akeno, A. Mukherjee, R. R. Dalal, B. J. Aronow, P. Koopman and T. L. Clemens, “Hypoxia Induces Chondrocyte-Specific Gene Expression in Mesenchymal Cells in Association with Transcriptional Activation of Sox9,” Bone, Vol. 37, No. 3, 2005, pp. 313-322. doi:10.1016/j.bone. 2005.04.040
[52] W. L. Grayson, F. Zhao, R. Izadpanah, B. Bunnell and T. Ma, “Effects of Hypoxia on Human Mesenchymal Stem Cell Expansion and Plasticity in 3D Constructs,” Journal of Cellular Physiology, Vol. 207, No. 2, 2006, pp. 331-339. doi:10.1002/jcp.20571
[53] L. A. Mylotte, A. M. Duffy, M. Murphy, T. O’Brien, A. Samali, F. Barry and E. Szegezdi, “Metabolic Flexibility Permits Mesenchymal Stem Cell Survival in an Ischemic Environment,” Stem Cells, Vol. 26, No. 5, 2008, pp. 1325-1336. doi:10.1634/stemcells.2007-1072
[54] S. Carrancio, N. Lopez-Holgado, F. M. Sanchez-Guijo, E. Villaron, V. Barbado, S. Tabera, M. Diez-Campelo, J. Blanco, J. F. San Miguel and M. C. Del Canizo, “Optimization of Mesenchymal Stem Cell Expansion Procedures by Cell Separation and Culture Conditions Modification,” Experimental Hematology, Vol. 36, No. 8, 2008, pp. 1014-1021. doi:10.1016/j.exphem.2008.03.012
[55] E. M. Horwitz, K. Le Blanc, M. Dominici, I. Mueller, I. Slaper-Cortenbach, F. C. Marini, R. J. Deans, D. S. Krause and A. Keating, “Clarification of the Nomenclature for MSC: The International Society for Cellular Therapy Position Statement,” Cytotherapy, Vol. 7, No. 5, 2005, pp. 393-395. doi:10.1080/ 14653240500319234
[56] M. Kassem, M. Kristiansen and B. M. Abdallah, “Mesenchymal Stem Cells: Cell Biology and Potential Use in Therapy,” Basic & Clinical Pharmacology & Toxicology, Vol. 95, No. 5, 2004, pp. 209-214. doi:10.1111/j.1742-7843.2004.pto950502.x
[57] M. Miura, Y. Miura, H. M. Padilla-Nash, A. A. Molinolo, B. Fu, V. Patel, B. M. Seo, W. Sonoyama, J. J. Zheng, C. C. Baker, W. Chen, T. Ried and S. Shi, “Accumulated Chromosomal Instability in Murine Bone Marrow Mesenchymal Stem Cells Leads to Malignant Transformation,” Stem Cells, Vol. 24, No. 4, 2006, pp. 1095-1103. doi:10.1634/stemcells.2005-0403
[58] A. S. Grigorian, P. V. Kruglyakov, U. A. Taminkina, O. A. Efimova, A. A. Pendina, A. V. Voskresenskaya, T. V. Kuznetsova and D. G. Polyntsev, “Alterations of Cytological and Karyological Profile of Human Mesenchymal Stem Cells during in Vitro Culturing,” Bulletin of Experimental Biology and Medicine, Vol. 150, No. 1, 2010, pp. 125-130. doi:10.1007/s10517-010-1086-x
[59] D. Rubio, J. Garcia-Castro, M. C. Martin, R. de la Fuente, J. C. Cigudosa, A. C. Lloyd and A. Bernad, “Spontaneous Human Adult Stem Cell Transformation,” Cancer Research, Vol. 65, No. 8, 2005, pp. 3035-3039.
[60] L. Basciano, C. Nemos, B. Foliguet, N. de Isla, M. de Carvalho, N. Tran and A. Dalloul, “Long Term Culture of Mesenchymal Stem Cells in Hypoxia Promotes a genetic Program Maintaining Their Undifferentiated and Multipotent Status,” BMC Cell Biology, Vol. 12, 2011, p. 12. doi:10.1186/1471-2121-12-12
[61] Y. Jin, T. Kato, M. Furu, A. Nasu, Y. Kajita, H. Mitsui, M. Ueda, T. Aoyama, T. Nakayama, T. Nakamura and J. Toguchida, “Mesenchymal Stem Cells Cultured under Hypoxia Escape from Senescence via Down-Regulation of p16 and Extracellular Signal Regulated Kinase,” Biochemical and Biophysical Research Communications, Vol. 391, No. 3, 2010, pp. 1471-1476. doi:10.1016/j.bbrc.2009.12.096
[62] H. Liu, W. Xue, G. Ge, X. Luo, Y. Li, H. Xiang, X. Ding, P. Tian and X. Tian, “Hypoxic Preconditioning Advances CXCR4 and CXCR7 Expression by Activating HIF-1Alpha in MSCs,” Biochemical and Biophysical Research Communications, Vol. 401, No. 4, 2010, pp. 509-515. doi:10.1016/j.bbrc. 2010.09.076
[63] C. C. Tsai, Y. J. Chen, T. L. Yew, L. L. Chen, J. Y. Wang, C. H. Chiu and S. C. Hung, “Hypoxia Inhibits Senescence and Maintains Mesenchymal Stem Cell Properties through Down-Regulation of E2A-p21 by HIF-TWIST,” Blood, Vol. 117, No. 2, 2011, pp. 459-469. doi:10.1182/blood-2010-05-287508
[64] S. Ohnishi, T. Yasuda, S. Kitamura and N. Nagaya, “Effect of Hypoxia on Gene Expression of Bone Marrow-Derived Mesenchymal Stem Cells and Mononuclear Cells,” Stem Cells, Vol. 25, No. 5, 2007, pp. 1166-1177. doi:10.1634/stemcells.2006-0347
[65] M. Shi, Z. W. Liu and F. S. Wang, “Immunomodulatory Properties and Therapeutic Application of Mesenchymal Stem Cells,” Clinical and Experimental Immunology, Vol. 164, No. 1, 2011, pp. 1-8. doi:10.1111/j.1365-2249.2011.04327.x
[66] C. D. Wan, R. Cheng, H. B. Wang and T. Liu, “Immunomodulatory Effects of Mesenchymal Stem Cells Derived from Adipose Tissues in a Rat Orthotopic Liver Transplantation Model,” Hepatobiliary and Pancreatic Diseases International, Vol. 7, No. 1, 2008, pp. 29-33.
[67] P. R. Crisostomo, Y. Wang, T. A. Markel, M. Wang, T. Lahm and D. R. Meldrum, “Human Mesenchymal stem Cells Stimulated by TNF-Alpha, LPS, or Hypoxia Produce Growth Factors by an NF Kappa B, but Not JNK-Dependent Mechanism,” American Journal of Physiology: Cell Physiology, Vol. 294, No. 3, 2008, pp. C675-C682. doi:10.1152/ajpcell.00437.2007
[68] E. H. Wu, H. S. Li, T. Zhao, J. D. Fan, X. Ma, L. Xiong, W. J. Li, L. L. Zhu and M. Fan, “Effect of hypoxia on the gene profile of human bone marrow-derived mesenchymal stem cells,” Acta Physiologica Sinica, Vol. 59, No. 2, 2007, pp. 227-232.
[69] C. Muir, L. W. Chung, D. D. Carson and M. C. Farach-Carson, “Hypoxia Increases VEGF-A Production by Prostate Cancer and Bone Marrow Stromal Cells and Initiates Paracrine Activation of Bone Marrow Endothelial Cells,” Clinical and Experimental Metastasis, Vol. 23, No. 1, 2006, pp. 75-86. doi:10.1007/s10585-006-9021-2
[70] Y. Wang, Y. Deng and G. Q. Zhou, “SDF-1Alpha/ CXCR4-Mediated Migration of Systemically Transplanted Bone Marrow Stromal Cells towards Ischemic Brain Lesion in a Rat Model,” Brain Research, Vol. 1195, No. 2008, pp. 104-112. doi:10.1016/j.brainres.2007.11.068
[71] X. Hu, S. P. Yu, J. L. Fraser, Z. Lu, M. E. Ogle, J. A. Wang and L. Wei, “Transplantation of Hypoxia-Preconditioned Mesenchymal Stem Cells Improves Infracted Heart Function via Enhanced Survival of Implanted Cells and Angiogenesis,” Journal of Thoracic and Cardiovascular Surgery, Vol. 135, No. 4, 2008, pp. 799-808. doi:10.1016/j.jtcvs.2007.07.071
[72] X. Mao, Q. Zeng, X. Wang, L. Cao and Z. Bai, “Angiogenic Potency of Bone Marrow Stromal Cells Improved by ex Vivo Hypoxia Prestimulation,” Journal of Huazhong University of Science and Technology (Medical Science), Vol. 24, No. 6, 2004, pp. 566-568. doi:10.1007/BF02911356
[73] H. Liu, S. Liu, Y. Li, X. Wang, W. Xue, G. Ge and X. Luo, “The Role of SDF-1-CXCR4/CXCR7 Axis in the Therapeutic Effects of Hypoxia-Preconditioned Mesenchymal Stem Cells for Renal Ischemia/Reperfusion Injury,” PLoS One, Vol. 7, No. 4, 2012, p. e34608. doi:10.1371/journal. pone.0034608

comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.